Strata Skin Sciences (FRA:E2O) Float Percentage Of Total Shares Outstanding: 62.26% (As of Jul. 11, 2026)


FRA:E2O Strata Skin Sciences Inc FRA:E2O
38 GF Score
Price €3.76
GF Value €59.29
! 5 Warning Signs
View Full Analysis

What is Strata Skin Sciences Float Percentage Of Total Shares Outstanding?

Strata Skin Sciences FRA:E2O 38 Float Percentage Of Total Shares Outstanding is 62.26% as of Jul. 11, 2026. GuruFocus rates FRA:E2O with a GF Score™ of 38/100 and a GF Value™ of €59.29. The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Strata Skin Sciences's float shares is 3.67 Mil. Strata Skin Sciences's total shares outstanding is 5.89 Mil. Strata Skin Sciences's float percentage of total shares outstanding is 62.26%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Strata Skin Sciences's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Strata Skin Sciences's Institutional Ownership is 1.32%.

FRA:E2O
38GF Score
Strata Skin Sciences Inc FRA:E2O
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Strata Skin Sciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Strata Skin Sciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=3.67/5.89
=62.26%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 62.26% mean?
Strata Skin Sciences (FRA:E2O) has a Float Percentage Of Total Shares Outstanding of 62.26% as of Jul. 11, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Strata Skin Sciences and its competitors.
Is Strata Skin Sciences' Float Percentage Of Total Shares Outstanding too high?
Strata Skin Sciences' current Float Percentage Of Total Shares Outstanding is 62.26%. Overall, Strata Skin Sciences has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Strata Skin Sciences' Float Percentage Of Total Shares Outstanding compare to ODYY and NUMD?
Strata Skin Sciences' Float Percentage Of Total Shares Outstanding of 62.26% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Strata Skin Sciences and its competitors. Strata Skin Sciences's current Float Percentage Of Total Shares Outstanding is 62.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Skin Sciences stock overvalued right now?
Strata Skin Sciences (FRA:E2O) has a current Float Percentage Of Total Shares Outstanding of 62.26%. The stock's GF Value™ is €59.29, compared to a current price of €3.76 — trading 93.7% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 62.26%. Strata Skin Sciences' overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Strata Skin Sciences (FRA:E2O), the current Float Percentage Of Total Shares Outstanding is 62.26% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Strata Skin Sciences (FRA:E2O) Overvalued in 2026?

Based on GuruFocus' analysis, Strata Skin Sciences stock appears to be undervalued. The current stock price of €3.76 is trading 93.7% below its estimated GF Value™ of €59.29.

Key valuation signals for FRA:E2O:

  • Float Percentage Of Total Shares Outstanding: 62.26%
  • GF Value™: €59.29 vs. price of €3.76 (93.7% below fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the FRA:E2O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Strata Skin Sciences Business Description

Other Exchanges SSKN:USA
Address 5 Walnut Grove Drive, Suite 140, Horsham, PA, USA, 19044
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo, and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver, and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
38GF Score

Get the complete analysis for FRA:E2O

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.76
Price
€59.29
GF Value